Sava Secures, 32M Series B for Wearable Glucose Sensor

Sava Technologies, a London-based innovator in wearable biosensor technology, has successfully closed a, 32.08 million ($36 million) Series B financing round. This significant capital injection is intended to accelerate the scale-up of its manufacturing…